002020 京新药业
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)9.90712.40111.61313.23513.954
总资产报酬率 ROA (%)6.9958.6488.0649.52210.031
投入资产回报率 ROIC (%)8.85110.97510.13011.70812.392

边际利润分析
销售毛利率 (%)50.07049.97450.57353.27555.470
营业利润率 (%)21.79220.28617.85720.01720.137
息税前利润/营业总收入 (%)20.63218.74616.36017.93719.095
净利润/营业总收入 (%)19.07417.29315.59017.66817.826

收益指标分析
经营活动净收益/利润总额(%)94.81293.43989.23292.62789.350
价值变动净收益/利润总额(%)2.520-3.9596.1035.7807.918
营业外收支净额/利润总额(%)0.0990.044-0.850-0.8400.212

偿债能力分析
流动比率 (X)1.6201.3611.6161.8072.316
速动比率 (X)1.2160.9891.3021.3811.839
资产负债率 (%)28.74129.22130.63129.75325.169
带息债务/全部投入资本 (%)5.0155.5666.4526.8795.501
股东权益/带息债务 (%)1,782.5831,604.4891,358.4101,261.6771,641.567
股东权益/负债合计 (%)246.448240.923225.326234.920295.028
利息保障倍数 (X)-17.468-12.098-12.154-9.375-17.614

营运能力分析
应收账款周转天数 (天)71.26757.10547.07944.51841.288
存货周转天数 (天)139.831125.062129.902147.920137.414